FdaApplication
NDA 020813
Identifiers
- fda_app_no: NDA020813
Properties
| Property | Value |
|---|---|
| applicant_name | HOFFMANN LA ROCHE INC |
| application_type | NDA |
| approval_date | 1997-12-23 |
Products (5)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| KLONOPIN RAPIDLY DISINTEGRATING | CLONAZEPAM | 0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING;ORAL |
| KLONOPIN RAPIDLY DISINTEGRATING | CLONAZEPAM | 0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING;ORAL |
| KLONOPIN RAPIDLY DISINTEGRATING | CLONAZEPAM | 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING;ORAL |
| KLONOPIN RAPIDLY DISINTEGRATING | CLONAZEPAM | 0.125MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING;ORAL |
| KLONOPIN RAPIDLY DISINTEGRATING | CLONAZEPAM | 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING;ORAL |
5 products